Neuroscience
Positron Emission Tomography
100%
Microglia
80%
Positron Emission Tomography
65%
In Vivo
63%
Istradefylline
62%
Striatum
61%
Dopaminergic
60%
Social Defeat
59%
Fluorine-18
53%
Adenosine A2A Receptor
53%
Parkinson's Disease
51%
ABC Transporter Subfamily B
51%
Receptor Antagonist
51%
Raclopride
49%
Lipopolysaccharide
40%
Behavior (Neuroscience)
32%
Receptor
31%
Cell Density
28%
Blood Brain Barrier
28%
Serotonin Transporter
28%
Dopamine Receptor D2
25%
Female Rats
25%
CGS-21680
25%
Receptor Agonists
25%
Gene Expression
25%
Social Behavior
20%
Anhedonia
18%
Hippocampus
15%
Corticosterone
14%
Frontal Lobe
14%
Brain Tumor
12%
Neurotoxicity
12%
Response Priming
12%
Real-Time Polymerase Chain Reaction
12%
Macrophage
12%
Transcriptomics
12%
RNA Sequence
12%
Dopaminergic Neuron
11%
Social Interaction
11%
Tyrosine Hydroxylase
10%
Cerebellum
9%
Polyinosinic:polycytidylic Acid
9%
Neuroreceptor
9%
Translocator Protein
8%
Locomotion
8%
Eicosanoid Receptor
7%
Agonist
7%
Adenosine
7%
Receptor Binding
7%
Midbrain
6%
Keyphrases
Tariquidar
51%
Dose Assessment
51%
Depressive-like Behavior
43%
P-glycoprotein Activity
42%
Blood-brain Barrier
29%
Positron Emission Tomography
29%
P-glycoprotein Inhibitor
28%
Repeated Social Defeat
28%
Serotonin Transporter Availability
28%
Motor Performance
25%
Adenosine A2A Receptor Antagonist
25%
D2 Receptor Ligands
25%
Dopaminergic System
25%
A2A Antagonists
25%
Rat Model of Parkinson's Disease
25%
KW-6002
25%
Striatum
25%
Neuroinflammation
25%
Tumor-infiltrating Macrophages
25%
Spontaneous Remission
25%
Male Rats
25%
Dopamine D2/3 Receptor
25%
Positron Emission Tomography Study
25%
Stress-induced
25%
Chronic Stress
25%
Remission
17%
P-glycoprotein (P-gp)
14%
Small Changes
14%
Raclopride
14%
Dose-response Curve
13%
High Sensitivity
11%
Microglial Priming
10%
Depression Level
9%
Ethical Limitations
8%
Radiotracer
8%
Sigmoidal Curve
7%
P-glycoprotein Substrate
7%
Compartmental Model
7%
Tissue Compartments
7%
Blood Data
7%
Neurodegenerative Diseases
7%
Post-mortem Analysis
7%
PBR28
7%
A2A Agonist
7%
6-hydroxydopamine (6-OHDA)
7%
PET Scan
7%
Parkinson's Disease Model
7%
Motor Function
7%
Dopaminergic Neuron Loss
7%
Monoaminergic Transmission
7%
Medicine and Dentistry
Neuroinflammation
63%
Parkinson's Disease
51%
Istradefylline
51%
Dopaminergic System
51%
Positron Emission Tomography
36%
Striatum
36%
Carbon 11
35%
Microglia
27%
Adenosine
27%
Proton Therapy
25%
Bragg Peak
25%
Motor Performance
25%
Receptor Antagonist
25%
Raclopride
17%
Positron Emission Tomography
14%
Brain Tumor
12%
Morphology
12%
Biological Activity
12%
Real-Time Polymerase Chain Reaction
12%
Immune Response
12%
Upregulation
12%
RNA Sequence
12%
Neurotoxicity
12%
Brain Radiation
12%
Proton Irradiation
12%
Pediatrics
12%
Macrophage
12%
Gene Expression
12%
Gene Expression Profiling
12%
Transcriptomics
12%
Contralateral
11%
Dopaminergic Neuron
11%
Symptom
11%
Tyrosine 3 Monooxygenase
10%
Biological Marker
6%
Major Depressive Episode
6%
Serositis
6%
Glucose Metabolism
6%
Neuroreceptor
6%
Human Study
6%
Depression
6%
Imaging Technique
6%
Oxidopamine
5%
